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a b s t r a c t
Evidence suggests that individualswho aremore obesemay bemore responsive to stress. Stress activates
the sympathetic nervous system (SNS) and the adipose-tissue cytokine leptin stimulates SNS activity in
animals. We examined the relationship between adiposity, leptin and physiological responses to acute
laboratory stress in 67women.Wepredicted that individualswith greater adiposity and/or higher plasmaeywords:
sychological stress
diposity
eptin
ytokines
ardiovascular reactivity
leptin would be more stress-responsive. Adiposity was unrelated to cardiovascular or neuroendocrine
stress reactivity. However, women with larger waists had greater stress-induced increases in plasma
leptin and interleukin-1 receptor antagonist (IL-1Ra). Similarly,womenwithhigherbasal leptindisplayed
greater stress-induced increases in heart rate and plasma interleukin-6, and larger decreases in heart rate
variability and cardiac pre-ejectionperiod.Heightened cardiovascular and inﬂammatory stress responses
are predictive of future cardiovascular risk. Our ﬁndings suggest that the cytokines leptin and IL-1Ramay
ion bplay a role in the associat
. Introduction
The prevalence of obesity has risen sharply in recent years,
eaching epidemic proportions world-wide. According to latest
gures from the World Health Organisation approximately 1.6
illion adults are currently overweight (body mass index, BMI
25kgm−2), and at least 400 million are clinically obese (BMI
30kgm−2). These ﬁgures are estimated to reach an alarming 2.3
illionand>700millionby2015 (WHOGlobal InfoBase, 2006).Obe-
ity is a major risk factor for several chronic conditions including
ypertension, cardiovascular disease (CVD), type 2 diabetes, and
ertain types of cancer and as such poses a major challenge to
ublic health care (Lavie et al., 2009). Understanding the biological
echanisms linking obesity and health is therefore of fundamental
mportance.
Psychological stress is associated with an increased risk of
ypertension and CVD and evidence emerging in the past decade
uggests that individualswho aremore obesemay bemore respon-
ive to stress. Two of the principle pathways activated by stress
re the hypothalamic–pituitary–adrenal axis, leading to elevations
n circulating glucocorticoids and the sympathetic nervous system
SNS), resulting in increases in blood pressure, heart rate and cir-
ulating catecholamines (Black, 2006). Studies have shown that
omen with a larger waist circumference or waist–hip ratio have
eightened cortisol responses to acute laboratory stress, as well as
mpaired dexamethasone suppression of cortisol (Epel et al., 2000;
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Pasquali et al., 2002). Similarly, central obesity has been associated
with elevatedorprolonged cardiovascular responses to acute stress
in some but not all studies (Steptoe and Wardle, 2005; Goldbacher
et al., 2005; Carroll et al., 2008; Davis et al., 1999; Waldstein et al.,
1999; Barnes et al., 1998), and a recent report found larger corti-
sol and cardiovascular responses to public speaking stress in obese
versus non-obese women (Benson et al., 2009).
The biological mechanisms linking obesity and stress reactiv-
ity are poorly understood. Adipose tissue is now recognised as a
major endocrine organ that secretes signalling molecules playing
a central role in inﬂammation, weight regulation and metabolic
function including cytokines (Trayhurn, 2005). Circulating levels of
the hormone-like cytokine leptin are markedly elevated in obese
humans and animals and correlatewith adipositymeasures in non-
obese healthy individuals (Considine et al., 1996; Trayhurn and
Bing, 2006). Leptin is secreted into the blood stream in proportion
to adipose tissue mass, and binds to receptors on speciﬁc hypotha-
lamic nuclei to regulate energy balance by reducing appetite and
stimulating SNS activity (Trayhurn and Bing, 2006). In rodents,
acute systemic or central leptin infusion increases sympathetic
nerve activity (SNA) to thermogenic tissues such as brown adi-
pose tissue (BAT) as well as non-thermogenic organs including
kidneys and adrenal glands (Ren, 2004). Similarly, chronic leptin
infusion increases heart rate, arterial blood pressure and circu-
lating catecholamines, and these effects are inhibited by 1 and
Open access under CC BY-NC-ND license.1/2 adrenergic antagonists (Ren, 2004; da Silva et al., 2006).
The relationship between leptin and SNS activity in humans is
less clear. Elevated plasma leptin levels have been reported in
patientswith hypertension, compared to normotensive individuals
(Thomopoulos et al., 2009). Similarly, cross-sectional studies have
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ound positive associations between circulating leptin and sympa-
hetic activity indexed by blood pressure, heart rate and heart rate
ariability in obese and lean normotensive humans (Bravo et al.,
006; Flanagan et al., 2007; Ma et al., 2009), and a recent prospec-
ive analyses of 489 normotensive men showed that individuals
ith high serum leptin levels had a 33% increased risk of devel-
ping hypertension over 8 years, independent of BMI (Galletti et
l., 2008). Nevertheless, most intervention studies have found no
ffect of either acute or chronic leptin infusion on SNS activity in
umans (Hukshorn et al., 2003; Brook et al., 2007; Mackintosh and
irsch, 2001; Chanet al., 2007). It is conceivable that the sympatho-
ctivating effects of leptin in humansmay bemore apparent under
onditions of heightened SNS activation induced by factors such as
sychological stress.
We set out to investigate the relationship between adiposity,
eptin and physiological responses to acute psychological stress in
sample of healthy youngwomen.We predicted that womenwith
reater adiposity would have heightened or prolonged cardiovas-
ular, neuroendocrine and inﬂammatory responses to stress. We
lso predicted that leptinwould potentiate sympathetic cardiovas-
ular reactivity to stress, so that women with higher basal plasma
eptin levels would have larger cardiovascular stress responses.
. Methods
.1. Sample
Sixty-nine female student volunteers were recruited from University College
ondon. Participants were aged between 18 and 25 years, and were screened by
tructured interview to ensure that they were healthy, not taking any medication
nd had no previous history of any relevant physical or mental illness. They were
nstructed not to take antibiotics, ibuprofen or aspirin for 10 days prior to the study
nd to avoid caffeine, alcohol and excessive exercise during the 12h prior to test-
ng. On the day of the study, participants were advised to eat a low fat breakfast
nd were provided with a standardised low fat lunch consisting of vegetable cous-
ous, fruit salad and fresh orange juice. Two participants were excluded from the
nal analyses since one was extremely obese (BMI 43.3) and another was greatly
nderweight (BMI 15.6). The study was approved by the joint University College
ondon/University College London Hospital Committee on the Ethics of Human
esearch and all participants gave their informed consent. We chose to study a
ealthy population with a wide range of adiposity levels rather than speciﬁcally
omparing obese versus non-obese individuals, since obese individuals are more
ikely to have co-morbid conditions such as diabetes or hypertension that may have
nﬂuenced our measures.
.2. Anthropometric measures
Anthropometric measures were taken by a research nurse at the beginning of
he session. Height was measured to the nearest 0.1 cm using the Frankfort plane
o standardise the measurement. Body weight was measured to the nearest 0.1 kg.
odymass index (BMI)was calculated as bodyweight in kilogramsdividedbyheight
nmetres squared.Waist circumferencewasmeasuredmidway between the lowest
ib and ileac crest. Body fat mass was estimated using a Bodystat 1500 bioelectrical
mpedance body composition analyses device (Bodystat, Douglas, Isle of Man). Fat
ercentage was calculated as fat weight divided by total (fat + lean) body weight.
.3. Autonomic and neuroendocrine measures
Cardiovascular data for the study were collected continuously and then aver-
ged over speciﬁed 5min trials. Blood pressurewasmonitored from the ﬁnger using
Portapres 2, a portable version of the Finpres device (TNO-TPD Biomedical Instru-
entation,Amsterdam,TheNetherlands).Heart rate andheart ratevariability (HRV)
ere assessed by impedance cardiography (ICG; VU-AMS, Amsterdam, The Nether-
ands) as described previously (Willemsen et al., 1996). HRV was calculated as the
oot mean square of successive R-R interval differences (RMSSD). A reduction in
MSSD indicates a shift in cardiac sympathovagal balance towards sympathetic con-
rol over the rhythm of the heart (Malik, 1996). Cardiac pre-ejection period (PEP)
asmeasured as an index of cardiac sympathetic drive (Sherwood et al., 1990). One
inute ensemble averages were derived for the ICG for each minute of tasks and
veraged. PEP was deﬁned as the interval between R-wave and B-point plus a ﬁxed
–R interval of 48ms. Cortisol was measured in saliva samples obtained through-
ut the session. Saliva was collected using Salivettes (Sarstedt, Inc. Leicester, UK)
nd stored at −80 ◦C prior to analyses. Salivary cortisol was analyzed using a com-
ercially available time-resolved immunoassaywith chemiluminescence detection
CLIA; IBL-Hamburg, Hamburg, Germany), at the Technical University of Dresden,gy 86 (2011) 114–120 115
Germany. This assay had a detection limit of 0.16ng/ml and intra-and inter-assay
coefﬁcients of variation of <10 and <12% respectively.
2.4. Immune measures
For assessment of circulating cytokines, blood samples (10ml) were drawn
using a 21-gauge butterﬂy needle into Vacutainer tubes containing EDTA as an
anti-coagulant, then centrifuged immediately at 1250× g for 10min at room tem-
perature. The plasma layer was removed, aliquoted and stored at −80 ◦C until
analyses. Plasma IL-6 levels were measured using a high-sensitivity two-site
enzyme-linked immunosorbent assay (ELISA) from R & D Systems (Oxford, UK).
This assay had a detection limit of 0.09pg/ml with intra- and inter-assay coefﬁ-
cients of variation (CVs) of 5.3 and 9.2% respectively. Plasma IL-1Ra concentrations
were measured using a commercial ELISA from R & D Systems, with a detection
limit of 15pg/ml and intra-and inter-assay CVs of <10%. Plasma leptin levels were
assessed using a commercial ELISA from Ray Biotech at Insight Biotechnology Ltd.
(Middlesex, UK). This assay had a detection limit of 6pg/ml and intra-and interas-
say CVs of <10% and <12% respectively. Plasma samples were diluted 1:200 prior to
leptin analyses.
2.5. Behavioural tasks
Mental stress was induced by two 5-min behavioural tasks, administered under
time pressure. The ﬁrst was a computerized Stroop task, involving the successive
presentation of target color words (e.g. red) printed in a different color (e.g. green).
The taskwas topress a computer key that corresponded to thepositionat thebottom
of the screen of the name of the color in which the target word was printed. The
second task was presented after an interval of 5min and involved simulated public
speaking. Participants were presented with a hypothetical scenario in which they
had been wrongly accused of shoplifting, and were instructed to give a speech in
their defense by addressing the camera directly in front of them. Theywere told that
their speech would be video recorded and later judged for efﬁcacy and ﬂuency. The
experimenter remained in the room with the participant during each of the tasks,
and instructed them when to start and stop.
2.6. Laboratory procedure
All sessionswere run in the afternoon in a light and temperature-controlled lab-
oratory, and participants were tested individually. They were provided with water
butwere not allowed to eat during testing. Anthropometricmeasureswere obtained
and the impedance cardiogram was ﬁtted for continuous assessment of heart rate,
HRV and cardiac PEP. Participants were then seated comfortably and ﬁtted with
ﬁnger cuffs so that blood pressure (BP) could be monitored using the Portapres-2.
A venous cannula was inserted into the lower arm for blood sampling, and they
were left to rest for 30min. Cardiovascular measures (BP, heart rate, HRV and car-
diac PEP) were recorded for the last 5min of the baseline rest period, then a saliva
sample was obtained and a baseline blood sample was drawn. At this time, partici-
pants were asked to rate their subjective feelings of stress on a 7-point Likert scale
ranging from 1= low to 7=high. Next, the two tasks were administered in a ﬁxed
order. Five-minute recordings of cardiovascular activity were made during each of
the tasks and cortisol samples and subjective stress ratingswere obtained after each
task. Following the tasks, a second blood sample was taken and participants rested
for a further 45min. Additional recordings of cardiovascular activity were obtained
at 10–15, 25–30 and 40–45min post-tasks, and a third blood sample was drawn at
45min. Further measures of subjective stress and cortisol were obtained at 15, 30
and 45min post-task.
2.7. Statistical analyses
First, we tested whether the tasks used in our study were indeed stressful,
by assessing participants’ subjective and physiological responses to these tasks
using repeated measures analyses of variance (ANOVA). The repeated measures
analyses of subjective stress and salivary cortisol involved six trials (baseline, post-
Stroop, post-speech, 15, 30 and 45min post-tasks). Similarly, analyses of heart rate,
HRV, cardiac PEP and blood pressure involved six trials (baseline, Stroop, speech,
10–15, 25–30 and 40–45min post-tasks), while the analyses of plasma cytokines
involved three trials (baseline, immediately post-tasks and 45min post-task). The
Greenhouse-Geisser correction of degrees of freedom was applied when sphericity
assumptions were violated. The distribution of plasma leptin was skewed so data
were square root transformed before analyses. Heart rate variability (RMSSD) data
were also skewed and were log transformed, however raw values are presented for
comparability with other studies. Post hoc tests were conducted using Tukey’s least
signiﬁcant difference (LSD) test.
We then investigated the association between adiposity measures and physio-
logical stress responses using amultiple linear regression approach. Three aspects of
physiological response were analyzed: baseline levels, stress reactivity (computed
as the change in levels between baseline and stress) and stress recovery (computed
as the change between baseline and 45min post-task). Age, smoking status and
ethnicity were included in all models as covariates. In regressions involving reactiv-
ity and recovery measures, baseline levels of the relevant dependent measure (HR,
116 L. Brydon / Biological Psycholo
Table 1
Participant characteristics (n=67).
Mean s.d. Range
Age 21.3 2.1 18–25
Smoker (%) 17.9
Ethnicity (% white) 66.7
Weight (kg) 62.0 10.3 47.3–93.8
Waist (cm) 70.3 7.9 57.0–95.0
BMI (kg/m2) 23.2 3.1 18.4–34.0
Body fat (%) 25.7 5.4 10.1–40.5
Subjective stress rating 2.0 1.1 1.0–6.0
Salivary cortisol (nmol/l) 5.5 2.5 1.8–13.7
Systolic BP (mmHg) 111.5 10.1 90.0–132.0
Diastolic BP (mmHg) 65.0 8.8 41.3–88.0
Heart rate (bpm) 72.2 8.7 51.8–91.7
HRV (ms) 56.0 29.1 19.4–174.2
Cardiac PEP (ms) 123.2 8.8 106.8–148.0
Plasma leptin (ng/ml) 35.7 22.0 5.7–105.5
Plasma IL-6 (pg/ml) 0.71 0.46 0.27–1.72
Plasma IL-1Ra (pg/ml) 176.9 73.0 98.7–480.1
HbA1c 4.77 0.27 3.9–5.2
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wbbreviations: BP, blood pressure; HbA1c, glycated haemoglobin; HRV, heart rate
ariability; PEP, pre-ejectionperiod; IL-6, interleukin-6; IL-1Ra, interleukin-1 recep-
or antagonist.
RV, etc.) were included as additional covariates in themodel. The same regression
pproachwas used to assess the relationship between basal plasma leptin levels and
hysiological stress responses. This time adiposity measures (BMI, waist circumfer-
nce and percentage body fat) were also included as covariates, since adiposity is a
ajor determinant of leptin levels and is associated with stress reactivity. Results
re presented as standardised regression coefﬁcients (ˇ) with standard errors (s.e.).
ssociations between adiposity (or leptin) measures and reactivity are illustrated
y displaying the mean cardiovascular and inﬂammatory responses of individuals
n the lower and higher tertiles of waist circumference or plasma leptin, adjusted
or covariates.
. Results
.1. Participant characteristics
Sample characteristics at baseline are presented in Table 1. Par-
icipantswere relatively youngwith amean age of 21. Themajority
ereWhite non-smokers. All were normotensive and had glycated
aemoglobin (HbA1c) levels in the normal range. Although they
ere not overweight on average, therewere large individual differ-
nces in adiposity measures; BMI ranged from 18.4 to 34.0 kgm−2,
aist circumference ranged from 57.0 to 95.0 cm and percentage
ody fat ranged from 10.1 to 40.5%. Participants also varied widely
n basal plasma leptin levels, ranging from 5.7 to 105.5ng/ml, with
mean concentration of 35.7ng/ml, s.d. 22.0. These levels are in the
xpected physiological range for non-fasting women (Rosenbaum
t al., 1996).
.2. Subjective, cardiovascular and neuroendocrine responses to
tress
Participants rated tasks as stressful with a mean score of
.64±1.1 and 4.42±1.4 during the Stroop and speech task
espectively. Subjective stress ratings returned to baseline lev-
ls during recovery, falling below baseline at 45min post-task (F
3, 196) =174.4, p<0.001). Participants’ blood pressure and heart
ate increased signiﬁcantly during the tasks, with mean increases
f 13.3mmHg (F (3, 167) =38.2, p<0.001) and 10.3mmHg (F (4,
21) =44.5, p<0.001) in systolic BP and diastolic BP respectively,
nd an average rise of 11.5 bpm in heart rate (F (2, 149) =116.3,
<0.001). At the same time, tasks induced a substantial decrease
n participants’ HRV and cardiac PEP; HRV decreased by 18.6ms on
verage during tasks (F (2, 149) =42.4, p<0.001), and cardiac PEP
ecreased by 6.0ms on average (F (2, 131) =44.7, p<0.001). There
ere large individual differences in all cardiovascular responses.gy 86 (2011) 114–120
For example, changes in heart rate ranged from −1.8bpm to
+30.3bpm, changes in HRV ranged from −99.4ms to +4.8ms, and
changes in cardiac PEP ranged from −28.0ms to +13.0ms, during
tasks. In addition, there was a small but signiﬁcant (14.5%) rise in
salivary cortisol in response to tasks, returning to baseline levels
during the rest period (F (2, 122) =9.96, p<0.001).
3.3. Cytokine stress responses
Tasks induced a small but signiﬁcant increase in participants’
plasma levels of IL-6 (F (1, 78) =21.1, p<0.001) and leptin (F (2,
105) =26.3, p<0.001), with maximum levels detected at 45min
post-tasks. Plasma levels of IL-6 increased by 37% on average at
45min, with responses ranging from −0.45pg/ml to +1.72pg/ml.
Similarly, plasma leptin levels increased by 14% on average at
45min, with responses ranging from −6.7ng/ml to +20.2ng/ml. IL-
1Ra levels were not altered by stress in the sample as a whole.
However, there were large individual differences in this response,
with changes in plasma IL-1Ra ranging from −148.1pg/ml to
+124.2pg/ml at 45min post-task. Plasma concentrations of IL-
1Ra and leptin were positively correlated immediately post-stress
(r=0.30, p=0.023) and at 45min post-stress (r=0.32, p=0.020).
3.4. Adiposity and cardiovascular, neuroendocrine and immune
measures
There was a signiﬁcant relationship between adiposity and
diastolic BP. Baseline diastolic BP was associated with BMI,
waist circumference and percentage body fat (ˇ =0.29–0.37,
s.e. = 0.13–0.14, all p<0.05), independent of age, ethnicity and
smoking status. Similarly, stress-induced increases in diastolic BP
at 45min were related to percentage body fat (ˇ =0.33, s.e. = 0.13,
p=0.014) and waist (ˇ =0.26, s.e. = 0.14, p=0.059ns trend), inde-
pendent of age, ethnicity, smoking and baseline diastolic BP. There
were no associations between adiposity and any other cardiovas-
cular or neuroendocrine measures.
Basal plasma cytokine levels were related to adiposity, inde-
pendent of age, ethnicity and smoking. Baseline leptin was
associated with BMI, waist and percentage body fat (ˇ =0.49–0.62,
s.e. = 0.11–0.13, all p<0.001). Similarly, IL-6 levels were related
to BMI and percentage body fat (ˇ =0.28–0.29, s.e. = 0.13–0.14,
p<0.05), and basal plasma IL-1Ra was associated with waist
(ˇ =0.41, s.e. = 0.13, p=0.003). There was also a signiﬁcant rela-
tionship between central adiposity and cytokine stress responses.
Waist circumference was associated with individual differences
in stress-induced increases in plasma leptin immediately post-
task (ˇ =0.34, s.e. = 0.15, p=0.022) and stress-induced increases in
plasma IL-1Ra at 45min post-task (ˇ =0.32, s.e. = 0.15, p=0.040),
independent of age, ethnicity, smoking and baseline levels of the
respective cytokine. The relationship between waist and IL-1Ra
responses is illustrated in Fig. 1, showing mean plasma IL-1Ra
concentrations in individuals in the lowest and highest tertiles of
waist circumference. Peoplewith greater central adiposity had 15%
higher IL-1Ra levels at 45min post-task.
3.5. Basal leptin and cardiovascular, neuroendocrine and
immune measures
Plasma levels of leptin at baseline were signiﬁcantly related
to participants’ cardiovascular and inﬂammatory stress responses,
independent of age, smoking, adiposity and baseline measures
of the respective dependent variable. Speciﬁcally, basal lep-
tin was associated with stress-induced increases in heart rate
(ˇ =0.53, s.e. = 0.18,p=0.006) andwithdecreases inHRV (ˇ =−0.44,
s.e. = 0.18,p=0.015) andcardiacPEP (ˇ =−0.51, s.e. = 0.17,p=0.004)
during tasks, independent of covariates. There was also a pos-
L. Brydon / Biological Psycholo
Fig. 1. Mean plasma concentrations of interleukin-1 receptor antagonist (IL-1Ra)
a
d
h
a
i
i
e
l
t
F
r
l
s
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ivided into tertiles and data are presented for individuals with low (<67 cm) and
igh (>70 cm)waistmeasures. Values are adjusted for age, ethnicity, smoking status
nd baseline plasma IL-1Ra. Error bars are SEM.tive association between basal leptin levels and stress-induced
ncreases in IL-6 at 45min (ˇ =0.35, s.e. = 0.17, p=0.042). These
ffects are illustrated in Fig. 2 (A–D). Women in the highest versus
owest tertile of basal leptin had a 2.2-fold greater IL-6 response
o stress at 45min. Similarly, during tasks, women in the highest
ig. 2. Basal circulating leptin and cardiovascular and inﬂammatory stress responses. Mea
ate variability and (D) cardiac PEP in relation to baseline plasma leptin levels. Leptin level
eptin was divided into tertiles and data are presented for individuals with low (<4.8ng
moking status, BMI, waist circumference, % body fat, and baseline levels of the appropria
–R interval differences; PEP, pre-ejection period.gy 86 (2011) 114–120 117
leptin tertile had 187% greater increases in heart rate, 86% greater
reductions in HRV and >11-fold larger decreases in cardiac PEP.
All associations remained signiﬁcant when controlling for ethnic-
ity (p<0.05). There was no relationship between basal leptin and
measures of diastolic or systolic BP, salivary cortisol or plasma IL-
1Ra.
4. Discussion
This study examined the relationship between adiposity, cir-
culating leptin and physiological responses to acute laboratory
stress in women. Contrary to our predictions, we found no evi-
dence of an association between adiposity measures and either
cardiovascular or neuroendocrine reactivity to stress. However,
womenwithgreater total adiposityhad impairedpost-stress recov-
ery in diastolic BP. In addition, there was a positive relationship
between central adiposity and individual differences in cytokine
stress responses, such that women with a larger waist circumfer-
encehadgreater stress-induced increases in plasma levels of IL-1Ra
and leptin. In line with our hypotheses there was a signiﬁcant
association between participants’ basal plasma leptin levels and
cardiovascular reactivity to stress, such that women with higher
leptin levels displayed greater increases in heart rate and greater
decreases in heart rate variability and cardiac PEP during tasks.
Interestingly, women with elevated basal leptin also displayed
larger stress-induced increases in the inﬂammatory cytokine IL-6.
n stress-induced changes in (A) plasma interleukin-6 (IL-6), (B) heart rate, (C) heart
s were skewed andwere square root transformed prior to analyses. Baseline plasma
/ml) and high (>6.4ng/ml) transformed leptin levels. Values are adjusted for age,
te dependent variable. Error bars are SEM. RMSSD, root mean square of successive
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The lack of association between adiposity and cardiovascular
eactivity is somewhat surprising.However, not all previous studies
ave found a positive relationship between adiposity and cardio-
ascular stress reactivity, and the majority of those that did were
ither carried out in small samples of fewer than 25 participants
r in samples that were not representative of the general popu-
ation and did not adjust for confounding variables (Davis et al.,
999; Barnes et al., 1998; Waldstein et al., 1999; Goldbacher et al.,
005). Similar to our observations, a more recent analysis of 225
iddle-aged British civil servants found no association between
otal or central adiposity and cardiovascular stress reactivity, but
oundapositive relationshipbetween thesemeasuresand impaired
ost-stress recoveryof diastolic bloodpressure, independentof tra-
itional risk factors (Steptoe and Wardle, 2005). Furthermore, the
argest study to date carried out in 1647 adults from the West of
cotland Twenty-07 study, found a negative association between
diposity and cardiovascular reactivity such that thosewith greater
MI and waist–hip ratio as well as those categorised as obese dis-
layed smaller heart rate reactions to stress (Carroll et al., 2008).
he lack of association between adiposity and cortisol reactivity in
ur study is difﬁcult to interpret, since the tasks used were only
oderately stressful and cortisol responses were very small. More
ocially evaluative tasks eliciting more robust changes in cortisol
ay be required to adequately assess this relationship.
The positive association between central adiposity and cytokine
tress responses is interesting and adds to the existing literature
elating obesity and stress reactivity in humans. White adipose
issue (WAT), in particular visceral WAT, is a major source of lep-
in and IL-1Ra and the expression of these cytokines is markedly
ncreased in WAT of obese humans and animals (Juge-Aubry et al.,
003; Considine et al., 1996). Accordingly, serum levels of leptin
nd IL-1Ra are elevated approximately 4-fold and 7-fold respec-
ively in obese individuals, where they are positively correlated
ith BMI and % body fat (Considine et al., 1996; Meier et al.,
002). Unlike other adipose tissue depots, visceral WAT has a rich
lood and nerve supply and a high abundance of glucocorticoid
nd beta-adrenergic receptors (Black, 2006). Glucocorticoids stim-
late leptin gene expression in human and mouse adipocytes in
itro and increase circulating leptin levels in humans (Trayhurn
nd Bing, 2006; Masuzaki et al., 1997). Conversely -adrenergic
gonists inhibit leptin gene expression in adipocytes and lower cir-
ulating leptin levels in vivo (Trayhurn and Bing, 2006) whereas
hey increase plasma IL-1Ra levels in humans (Sondergaard et al.,
000). The higher expression of cytokines in visceral WAT coupled
ith a greater density of stress hormone receptors, may explain
hy we found relationships between cytokine responses and cen-
ral but not total adiposity (Black, 2006). Togetherwith the existing
vidence, our results suggest that adipose tissue may be an impor-
ant source of stress-responsive cytokines.
Notably, adipose tissue is heterogeneous and contains a stro-
al vascular cell population including monocytes, as well as
dipocytes (Weisberg et al., 2003). Leptin receptors are expressed
nmonocytes, and leptin stimulatesmonocyte production of other
ytokines including IL-1Ra and IL-6 by binding to these recep-
ors (La Cava and Matarese, 2004; Gabay et al., 2001). It is thus
onceivable that basal or stress-induced increases in leptin may
rive IL-1Ra and IL-6 responses to stress. This may explain why
e found an association between waist circumference and lep-
in immediately post-stress whereas waist was associated with
L-1Ra levels at 45min. Supporting a relationship between these
wo cytokines, plasma concentrations of leptin and IL-1Ra were
ositively correlated both immediately post-stress and at 45min.
lthough adipositywas not related to IL-6 stress responses,women
ith higher basal leptin levels displayed larger increases in IL-6 fol-
owing tasks, indicating that elevated leptin levels may drive this
nﬂammatory response.gy 86 (2011) 114–120
The observed relationship between basal plasma leptin levels
and cardiovascular reactivity to stress is consistent with previous
reports in humans and animals supporting a sympatho-activating
effect of leptin (Ren, 2004; da Silva et al., 2006; Thomopoulos et
al., 2009; Bravo et al., 2006; Flanagan et al., 2007; Ma et al., 2009).
Although human leptin infusion studies have generated inconsis-
tent results, our ﬁndings suggest that leptin may potentiate SNS
activity during stress. The effects of leptin on SNS activity are
thought to be driven mainly by a central mechanism involving
the long form of the leptin receptor (OB-Rb) and melanocortin-3/4
receptors (MC3/4 R) in the hypothalamic arcuate nucleus (ARC).
In rodents, microinjection of leptin into the ARC increases arterial
pressure and sympathetic outﬂow to BAT and kidneys, whereas
lesions to the ARC blunt the thermogenic SNA response to leptin
(Rahmouni and Morgan, 2007). Similarly, central pharmacologi-
cal blockade or genetic ablation of MC3/4R in rodents abolishes
the hypertensive effects of chronic leptin infusion (da Silva et al.,
2009). In addition, leptin may promote sympathetic activity via
direct, non-neural pathways. Leptin receptors have been detected
in the heart and endothelium of blood vessels (Bjorbaek and Kahn,
2004), and a strong independent association between circulating
leptin andheart ratewas observed in heart transplant patientswith
sympathetic denervation, supporting a direct effect of leptin on
heart rate conceivably through cardiac leptin receptors (Winnicki
et al., 2001). The sympatho-activating effects of leptinmay bemore
apparent inwomen.Womenaregenerallymore ‘adipose’ thanmen,
withgreater totalbody fat andsigniﬁcantlyhigher leptin levelsboth
pre- and post-menopause (Rosenbaum et al., 1996). Furthermore,
two recent studies found a signiﬁcant correlation between circulat-
ing leptin levels, sympathetic autonomic activity and hypertension
inwomenbutnot inmen (Maet al., 2009; Flanaganet al., 2007), and
women display greater cardiovascular reactivity to certain types of
acute laboratory stress (Schmaus et al., 2008).
Heightened or prolonged sympathetic reactivity to acute stress
has been shown to predict future hypertension in initially nor-
motensive samples as well as an increased risk of cardiac events
in patients with documented cardiovascular disease (Treiber et al.,
2003; Flaa et al., 2008). Although few studies have examined the
prospective relationship between acute cytokine responses and
cardiovascular risk, we previously showed that IL-6 responses to
laboratory stress were predictive of 3-year elevations in BP in men
and women from the Whitehall II cohort (Brydon and Steptoe,
2005). IL-6 and leptin have a number of pro-atherogenic effects
including upregulation of endothelial cell adhesion molecules and
promoting smooth muscle cell proliferation and platelet aggre-
gation, and elevated circulating levels of these cytokines are
associatedwith a heightened risk of CVD (Gualillo et al., 2007). Sim-
ilarly IL-1Rahas anumber ofmetabolic effects that promote obesity
and insulin resistance (Meier et al., 2002; Juge-Aubry et al., 2003).
Therefore acute cardiovascular and cytokine stress responses may
become clinically relevant if repeated on a long-term basis.
This investigation was carried out in a sample of young, pre-
dominately white females and results may not generalise to other
populations. Cytokines weremeasured in non-fasting plasma sam-
ples, and there is some evidence that ingestion of food with a high
carbohydrate or fat content can alter circulating leptin levels in
animals (Houseknecht and Spurlock, 2003). However, most human
studies show only a long-termdietary effect of chronic overfeeding
on leptin (Houseknecht and Spurlock, 2003). A signiﬁcant propor-
tion (17.9%) of our participants smoked and smoking is known to
affect cardiovascular function and cytokine levels. However, results
remained signiﬁcantwhencontrolling for this factor.Heart rate and
HRV are regulated by both parasympathetic vagal withdrawal as
well as increases in sympathetic nerve activity, and it would have
been useful to include more direct measures of sympathetic activ-
ity such as catecholamines. Nevertheless, cardiac PEP is a strong
ycholo
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ndicator of sympathetic nerve activation (Sherwood et al., 1990).
e also did not control for menstrual cycle. However differences
n physiological stress reactivity across the menstrual cycle have
een inconsistent (Weidner andHelmig, 1990). Themultiple statis-
ical analyses performed increases the likelihood of type-1 errors in
ur results. Lastly, the cross-sectional nature of the study prevents
onclusions about the causal direction of associations between adi-
osity, leptin and stress-reactivity. Since leptin and IL-1Ra play an
mportant role in weight regulation and adipose tissue physiology,
tress-induced increases in these cytokinesmayalso impactobesity
evels (Trayhurn and Bing, 2006; Meier et al., 2002).
Nevertheless, our ﬁndings throw some light on the poten-
ial mechanisms linking obesity, stress and cardiovascular risk in
omen. Since visceral WAT is a major source of cytokines, central
diposity may increase cardiovascular risk by facilitating a pro-
therogenic response to stress. Similarly, by driving sympathetic
nd inﬂammatory stress responses, leptin may promote the devel-
pment of future cardiovascular disease. Further experiments are
equired to conﬁrm our observations in a larger sample includ-
ng equal numbers of both genders and to test whether there is
prospective association between adiposity or leptin, stress reac-
ivity and cardiovascular risk in humans.
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